Skip to main content
. 2019 Sep 3;10(10):2006–2012. doi: 10.1111/1759-7714.13187

Table 2.

Efficacy of ICI

Variables(N = 71) With severe grade CIP (N = 11) Without severe grade CIP (N = 60) P‐value
Best treatment effect of ICI 0.47
CR 0 (0) 1 (1.7)
PR 1 (9.1) 20 (33.3)
SD 3 (27.3) 14 (23.3)
PD 7 (63.6) 24 (40.0)
Not comparable 0 (0) 1 (1.7)
ORR 9.1% 35.6% 0.20
DCR 36.4% 59.3% 0.34

One patient had no target‐lesion which could be assessed based on the Response Evaluation Criteria in Solid Tumors version 1.

Data are presented as N (%).

CIP, checkpoint inhibitor pneumonitis; CR, complete response; DCR, disease control rate; ICI, immune checkpoint inhibitor; ORR, overall response rate; PD, progressive disease; PR, partial response; SD, stable disease.